The 4th edition of the International Symposium on Intra-Articular Treatment (ISIAT) took place in Prague last 5th to 7th of October 2017. Organized every two years across different European cities by Prof. Alberto Migliore (IT), this congress is, as its name suggests, focus on intra-articular management of joint disease including Read more…
LABRHA participated at the EULAR Congress, which took place from the 14th to the 17th of June 2017 in Madrid, and presented the very positive results of a study conducted on its product Fibromyalgine®, a phytotherapy solution designed for Fibromyalgia sufferers. The abstract MULTICENTER, PROSPECTIVE, CONTROLLED DOUBLE-BLIND STUDY COMPARING FIB-19-01 Read more…
LABRHA participated at the OARSI 2017 World Congress which took place from the 27th to the 30th of April 2017 in Las Vegas. . 1) HAppyMini® in the Trapeziometacarpal joint: first results presented at the OARSI Congress . The abstract SAFETY AND EFFICACY OF A SINGLE INJECTION OF MANNITOL-MODIFIED CROSSLINKED Read more…
LABRHA participated at the ACR Congress in Washington DC, which took place from the 11th to the 16th of November 2016, and displayed a poster presenting the results of a study conducted to identify the clinical and radiological factors associated with a lack of a relevant response to viscosupplementation (VS) Read more…
LABRHA participated in the 17th EULAR Congress which took place from the 8th to the 11th of June 2016 in London. 1) Predictive factors of failure of viscosupplementation in patients with knee Osteoarthritis. Results of a post-hoc analysis of a double blind, controlled non Inferiority trial. F. Eymard, T. Conrozier, Read more…